These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 18272374
1. Association study of the GAB2 gene with the risk of developing Alzheimer's disease. Chapuis J, Hannequin D, Pasquier F, Bentham P, Brice A, Leber I, Frebourg T, Deleuze JF, Cousin E, Thaker U, Amouyel P, Mann D, Lendon C, Campion D, Lambert JC. Neurobiol Dis; 2008 Apr; 30(1):103-6. PubMed ID: 18272374 [Abstract] [Full Text] [Related]
2. The GAB2 gene and the risk of Alzheimer's disease: replication and meta-analysis. Ikram MA, Liu F, Oostra BA, Hofman A, van Duijn CM, Breteler MM. Biol Psychiatry; 2009 Jun 01; 65(11):995-9. PubMed ID: 19118819 [Abstract] [Full Text] [Related]
3. Implication of GAB2 gene polymorphism in Italian patients with Alzheimer's disease. Nacmias B, Tedde A, Bagnoli S, Cellini E, Guarnieri BM, Piacentini S, Sorbi S. J Alzheimers Dis; 2009 Jun 01; 16(3):513-5. PubMed ID: 19276544 [Abstract] [Full Text] [Related]
4. Association analysis of brain-derived neurotrophic factor (BDNF) gene 196 A/G polymorphism with Alzheimer's disease (AD) in mainland Chinese. Bian JT, Zhang JW, Zhang ZX, Zhao HL. Neurosci Lett; 2005 Oct 14; 387(1):11-6. PubMed ID: 16054753 [Abstract] [Full Text] [Related]
5. Genetic analysis of tumor necrosis factor-alpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease. Wang B, Zhou S, Yang Z, Xie YC, Wang J, Zhang P, Lv Z, Zheng C, Ma X. J Neurol Sci; 2008 Jul 15; 270(1-2):148-51. PubMed ID: 18396294 [Abstract] [Full Text] [Related]
6. -1154G/A and -2578C/A polymorphisms of the vascular endothelial growth factor gene in Tunisian Alzheimer patients in relation to beta-amyloid (1-42) and total tau protein. Smach MA, Charfeddine B, Othman LB, Lammouchi T, Ltaief A, Nafati S, Dridi H, Bennamou S, Limem K. Neurosci Lett; 2010 Mar 19; 472(2):139-42. PubMed ID: 20138124 [Abstract] [Full Text] [Related]
7. Association study and meta-analysis of Alzheimer's disease risk and presenilin-1 intronic polymorphism. Rodríguez-Manotas M, Amorín-Díaz M, Cañizares-Hernández F, Ruíz-Espejo F, Martínez-Vidal S, González-Sarmiento R, Martínez-Hernández P, Cabezas-Herrera J. Brain Res; 2007 Sep 19; 1170():119-28. PubMed ID: 17719017 [Abstract] [Full Text] [Related]
8. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily. Bosco P, Caraci F, Copani A, Spada RS, Sortino MA, Salluzzo R, Salemi M, Nicoletti F, Ferri R. Neurosci Lett; 2007 Jun 04; 419(3):195-8. PubMed ID: 17498878 [Abstract] [Full Text] [Related]
9. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity. Nacmias B, Bagnoli S, Tedde A, Cellini E, Bessi V, Guarnieri B, Ortensi L, Piacentini S, Bracco L, Sorbi S. Arch Gerontol Geriatr; 2007 Jun 04; 45(2):201-6. PubMed ID: 17182125 [Abstract] [Full Text] [Related]
10. APOE dependent-association of PPAR-γ genetic variants with Alzheimer's disease risk. Combarros O, Rodríguez-Rodríguez E, Mateo I, Vázquez-Higuera JL, Infante J, Berciano J, Sánchez-Juan P. Neurobiol Aging; 2011 Mar 04; 32(3):547.e1-6. PubMed ID: 19660836 [Abstract] [Full Text] [Related]
11. Deficiency of CARD8 is associated with increased Alzheimer's disease risk in women. Fontalba A, Gutiérrez O, Llorca J, Mateo I, Berciano J, Fernández-Luna JL, Combarros O. Dement Geriatr Cogn Disord; 2008 Mar 04; 26(3):247-50. PubMed ID: 18841008 [Abstract] [Full Text] [Related]
12. The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level. Pesaresi M, Batelli S, Prato F, Polito L, Lovati C, Scarpini E, Quadri P, Mariani C, Albani D, Forloni G. Neurobiol Dis; 2007 Mar 04; 25(3):609-13. PubMed ID: 17174555 [Abstract] [Full Text] [Related]
13. Association between enzymatic and non-enzymatic antioxidant defense mechanism with apolipoprotein E genotypes in Alzheimer disease. Kharrazi H, Vaisi-Raygani A, Rahimi Z, Tavilani H, Aminian M, Pourmotabbed T. Clin Biochem; 2008 Aug 04; 41(12):932-6. PubMed ID: 18505684 [Abstract] [Full Text] [Related]
14. Apolipoprotein E epsilon4 allele frequency in elderly depressed patients with and without cerebrovascular disease. Traykov L, Bayle AC, Latour F, Lenoir H, Seux ML, Hanon O, Péquignot R, Bert P, Moulin F, Cantegreil I, Wenisch E, Batouche F, Mehrabian S, Rotrou Jd, Rigaud AS. J Neurol Sci; 2007 Jun 15; 257(1-2):280-3. PubMed ID: 17337010 [Abstract] [Full Text] [Related]
15. Different implication of NEDD9 genetic variant in early and late-onset Alzheimer's disease. Tedde A, Bagnoli S, Piaceri I, Lucenteforte E, Bessi V, Bracco L, Mugelli A, Sorbi S, Nacmias B. Neurosci Lett; 2010 Jun 25; 477(3):121-3. PubMed ID: 20430066 [Abstract] [Full Text] [Related]
16. Association analysis of the paraoxonase-1 gene with Alzheimer's disease. Cellini E, Tedde A, Bagnoli S, Nacmias B, Piacentini S, Bessi V, Bracco L, Sorbi S. Neurosci Lett; 2006 Nov 20; 408(3):199-202. PubMed ID: 16996683 [Abstract] [Full Text] [Related]